First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients

First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients

Abstract Background Serum hepatitis B core-related antigen (HBcrAg) is a potential surrogate marker for intra-hepatic covalently-closed circular DNA in chronic hepatitis B (CHB). We aimed to study the profiles of serum HBcrAg in CHB patients treated with first-line nucleos(t)ide analogues (NA): ente...

Full description

Bibliographic Details
Main Authors: Lung-Yi Mak, Danny Ka-Ho Wong, Ka-Shing Cheung, Wai-Kay Seto, James Fung, Man-Fung Yuen
Format: Article
Language:English
Published: BMC 2021-03-01
Series:BMC Gastroenterology
Subjects:
Hepatitis B
Entecavir
Tenofovir
Hepatitis B core-related antigen
Nucleotide analogue
Online Access:https://doi.org/10.1186/s12876-021-01711-x

Internet

https://doi.org/10.1186/s12876-021-01711-x

Similar Items